Details for Patent: 11,207,280
✉ Email this page to a colleague
Which drugs does patent 11,207,280 protect, and when does it expire?
Patent 11,207,280 protects ADRENALIN and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 11,207,280
| Title: | Epinephrine compositions and containers |
| Abstract: | The inventive subject matter provides ready-to-administer, preferably anti-oxidant free, epinephrine compositions with improved stability, and methods for preparing the same. Contemplated compositions can be packaged using blow-fill-seal technology or packaged into flexible IV bags and maintain degradation of the epinephrine at a level of less than 5 wt % when stored over at least one months at between 2-40° C. |
| Inventor(s): | Akasapu Prem Sagar, Soppimath Kumaresh, Puri Reema Ajitkumar, Ilitchev Iouri V., Patel Milan, Tendulkar Pooja H. |
| Assignee: | Nevakar Injectables Inc. |
| Application Number: | US16821785 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,207,280
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-001 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-002 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-003 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-004 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-005 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,207,280
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3093725 | ⤷ Try a Trial | |||
| World Intellectual Property Organization (WIPO) | 2019183416 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
